Advanced search
Publication Cover
Acta Oncologica Volume 51, 2012 - Issue 1
Journal homepage
892
Views
8
CrossRef citations to date
0
Altmetric
Letter

Therapy-related myeloid neoplasms in epithelial ovarian cancer patients carrying BRCA1 mutation: Report of two cases

Bohuslav MelicharDepartment of Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic;Department of Oncology & Radiotherapy, Charles University Medical School & Teaching Hospital, Hradec Králové, Czech RepublicCorrespondence[email protected]
,
Jan LacoDepartment of Pathology, Charles University Medical School & Teaching Hospital, Hradec Králové, Czech Republic
,
Petra FridrichováDepartment of Medical Genetics, Charles University Medical School & Teaching Hospital, Hradec Králové, Czech Republic
,
Martin ŠimkovičDepartment of Internal Medicine, Charles University Medical School & Teaching Hospital, Hradec Králové, Czech Republic
,
Tomáš PapajíkDepartment of Hematologic Oncology, Palacký University Medical School & Teaching Hospital, Olomouc, Czech Republic
&
Lenka ForetováDepartment of Cancer Epidemiology and Genetics, Masaryk Memorial Cancer Institute, Brno, Czech Republic
Pages 136-138 | Received 24 May 2011, Accepted 31 May 2011, Published online: 22 Aug 2011

References

  • McGuire WP, Hoskins WJ, Brady MF, Kucera PR, Partridge EE, Look KY, . Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer. N Engl J Med 1996;334:1–6.
  • Dizon DS, Dupont J, Anderson S, Sabbatini P, Hummer A, Aghajanian C, . Treatment of recurrent ovarian cancer: A retrospective analysis of women treated with single-agent carboplatin originally treated with carboplatin and paclitaxel. The Memorial Sloan-Kettering Cancer Center experience. Gyn Oncol 2003;91:584–90.
  • Markman M, Liu PY, Wilczynski S, Monk B, Copeland LJ, Alvarez RD, . Phase III randomized trial of 12 versus 3 months of maintenance paclitaxel in patients with advanced ovarian cancer after complete response to platinum and paclitaxel-based chemotherapy: A Southwest Oncology Group and Gynecologic Oncology Group trial. J Clin Oncol 2003;21:2460–5.
  • Travis LB, Holowaty EJ, Bergfeldt K, Lynch CF, Kohler BA, Wiklund T, . Risk of leukemia after platinum-based chemotherapy for ovarian cancer. N Engl J Med 1999;340: 351–7.
  • Cole M, Strair R. Acute myelogenous leukemia and myelodysplasia secondary to breast cancer treatment: Case studies and literature review. Am J Med Sci 2010;339:36–40.
  • Kennedy RD, Quinn JE, Mullan PB, Johnston PG, Harkin DP. The role of BRCA1 in the cellular response to chemotherapy. J Natl Cancer Inst 2004;96:1659–68.
  • Chetrit A, Hirsch-Yechezkel G, Ben-David Y, Lubin F, Friedman E, Sadetzki S. Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: The national Israeli study of ovarian cancer. J Clin Oncol 2008;26:20–5.
  • Risch HA, McLaughlin JR, Cole DEC, Rosen B, Bradley L, Kwan E, . Prevalence and penetrance of germline BRCA1 and BRCA2 mutations in a population series of 649 women with ovarian cancer. Am J Hum Genet 2001;68: 700–10.
  • Vardiman JW, Thiele J, Arber DA, Brunning RD, Borowitz MJ, Porwit A, . The 2008 revision of the world organization (WHO) classification of myeloid neoplasms and acute leukemia: Rationale and important changes. Blood 2009;114: 937–51.
  • Friedenson B. The BRCAI/2 pathway prevents hematologic cancers in addition to breast and ovarian cancers. BMC Cancer 2007;7:1–11.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.